The Pharmacy and Poisons Board (PPB) in Kenya has issued a strong warning against the unsupervised use of Semaglutide, commonly known by its brand name Ozempic, for weight loss. The PPB emphasized that Ozempic is a prescription-only medicine approved for the treatment of type 2 diabetes and should not be used outside this purpose.
Ozempic and Its Approved Medical Use
According to the PPB, Semaglutide is approved strictly for adults with type 2 diabetes mellitus, especially those whose condition is poorly controlled by other treatments. However, the growing trend of using Ozempic for weight loss has raised serious concerns among health authorities.
Health Risks of Unsupervised Use
The PPB highlighted the adverse side effects of misusing Ozempic, particularly when used for weight loss without proper medical supervision. Some of the most common and serious side effects of Semaglutide include:
- Low blood sugar (hypoglycemia)
- Eye complications
- Gastroesophageal reflux disease (acid reflux)
- Intestinal obstruction
These side effects can vary from mild to severe and pose significant health risks, especially when the drug is taken outside of its intended use.
Public Advisory
The Pharmacy and Poisons Board urged the public to avoid self-prescribing Ozempic and seek proper medical guidance before using the drug. They also encouraged people to report any side effects or poor-quality products through the Pharmacovigilance Electronic Reporting System, or directly via email ([email protected]) or phone (+254 795 743 049).
How Ozempic Works for Diabetes and Weight Loss
While Ozempic is not approved for weight loss, it works by mimicking a natural hormone released after meals to regulate blood sugar levels. It helps with insulin production, slows stomach emptying, and reduces sugar production in the liver. These effects may support weight loss, but this should only be done under strict medical supervision, particularly in diabetic patients.
Conclusion
The Pharmacy and Poisons Board remains committed to ensuring the quality, safety, and efficacy of all health products in Kenya. With the rising misuse of Ozempic for weight loss, the PPB continues to encourage the public to use medicines only for their approved purposes and to consult healthcare providers for safe and effective treatment options.
